HORIBA, Ltd. (Headquarter in Kyoto, Japan) and HORIBA ABX S.A.S. (Headquarter in Montpellier, France, referred to as HORIBA Medical) announced today that it has entered into a long term agreement with Siemens Healthcare Diagnostics Inc. (Headquarter in NY, USA, referred to as Siemens Healthineers).
The agreement will combine the complementary innovative technology offerings of each company to address the multidisciplinary requirements of IVD*1 testing customers.
"Our long term vision and continuous investments coupled with our outstanding employees have resulted in innovative hematology technology solutions. I am extremely pleased that this long term vision has resulted in an alliance with Siemens Healthineers" said Mr. Atsushi Horiba, Chairman, President & CEO of HORIBA, Ltd.
"This alliance provides HORIBA Medical the opportunity to address the multidisciplinary requirements along with complementary innovative technology of Siemens Healthineers. HORIBA Medical will continue offering innovative technology solutions through its Yumizen*2 brand and current distribution channels." said Dr. Jai Hakhu, Executive Corporate Officer of HORIBA, Ltd. and President of HORIBA Medical.
HORIBA Medical will continue investing in innovative technologies for future IVD requirements.
*1 IVD (In-vitro diagnostics): The laboratory analysis of body substances (e.g., blood, saliva, stool, or urine) for specific analyses indicative of disease.
*2 Yumizen brand: Please refer to the web site. www.horiba.com/us/en/medical/yumizen/